GEMCITABINE, OXALIPLATIN, AND ANTI-CD20 THERAPY IS SAFE AND EFFECTIVE IN CHILDREN AND YOUNG ADULTS WITH NON-HODGKIN LYMPHOMA UNFIT FOR INTENSIVE THERAPY. (October 2022)

Record Type:: Journal Article
Title:: GEMCITABINE, OXALIPLATIN, AND ANTI-CD20 THERAPY IS SAFE AND EFFECTIVE IN CHILDREN AND YOUNG ADULTS WITH NON-HODGKIN LYMPHOMA UNFIT FOR INTENSIVE THERAPY. (October 2022)
Main Title:: GEMCITABINE, OXALIPLATIN, AND ANTI-CD20 THERAPY IS SAFE AND EFFECTIVE IN CHILDREN AND YOUNG ADULTS WITH NON-HODGKIN LYMPHOMA UNFIT FOR INTENSIVE THERAPY
Authors:: Bender, J.
Rubinstein, J.
Pommert, L.
Abstract:
Is Part Of:: Leukemia research. Volume 121(2022)Supplement
Journal:: Leukemia research
Issue:: Volume 121(2022)Supplement
Issue Display:: Volume 121, Issue 2022 (2022)
Year:: 2022
Volume:: 121
Issue:: 2022
Issue Sort Value:: 2022-0121-2022-0000
Page Start:: S63
Page End:: S64
Publication Date:: 2022-10
Subjects:: Leukemia -- Periodicals
Leukemia -- Periodicals
Leucémie -- Périodiques
Leukemia
Periodicals
Electronic journals
Electronic journals
616.9941905
Journal URLs:: http://www.sciencedirect.com/science/journal/01452126 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/S0145-2126(22)00300-9 ↗
Languages:: English
ISSNs:: 0145-2126
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5185.270000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 24198.xml